Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors

He Huang(University of Chicago), Hualiang Jiang(Shanghai Institute of Materia Medica), Liping Lin(Fujian Business University), Guangrong Qin(Institute for Systems Biology), Yonghua Xi(Shanghai University of Traditional Chinese Medicine), Weiliang Zhu(Nanjing University of Chinese Medicine), Jian Ding(Yuxi Normal University), Qi Jia(Lanzhou University), Jingui Ma(Chinese Academy of Sciences), Ying‐Yi Chen(Chang Gung University)
European Journal of Medicinal Chemistry
October 18, 2008
10.1016/j.ejmech.2008.09.051
Cited by 38

Related Papers

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
|Cell|2020|640
Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion
|Nature Neuroscience|2018|610
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
|Cell|2018|271